Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
ProQR Therapeutics NV banner

ProQR Therapeutics NV
F:0PQ

Watchlist Manager
ProQR Therapeutics NV Logo
ProQR Therapeutics NV
F:0PQ
Watchlist
Price: 1.812 EUR 1.34% Market Closed
Market Cap: €148m
Write Note Create Alert Ask AI

Wall St Price Targets

0PQ Price Targets Summary
ProQR Therapeutics NV

Wall Street analysts forecast 0PQ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0PQ is 9.233 EUR with a low forecast of 3.082 EUR and a high forecast of 16.019 EUR.

0PQ Lowest Forecast
Wall Street Target
€3.082
70% Upside
0PQ Average Forecast
Wall Street Target
€9.233
410% Upside
0PQ Highest Forecast
Wall Street Target
€16.019
784% Upside
Lowest Forecast
Price Target
3.082 EUR
70% Upside
Average Forecast
Price Target
9.233 EUR
410% Upside
Highest Forecast
Price Target
16.019 EUR
784% Upside
ProQR Therapeutics NV Competitors:
Price Targets
IBEX
Ibex Ltd
-2% Downside
VINP
Vinci Partners Investments Ltd
47% Upside
FAF
First American Financial Corp
9% Upside
LVO
LiveOne Inc
194% Upside
IBEX
Ibex Ltd
-2% Downside
VINP
Vinci Partners Investments Ltd
47% Upside
FAF
First American Financial Corp
9% Upside
LVO
LiveOne Inc
194% Upside
B
BRI
Britania PCL
14% Upside
CALM
Cal-Maine Foods Inc
18% Upside

Revenue
Forecast

51% / Year
Past Growth
50% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
51% / Year
Past Growth
50% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 12 years, the compound annual growth rate for Revenue has been 51%. The projected CAGR for the next 8 years is 50%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

What are analyst estimates?

Continue 0PQ Research

Summary
0PQ intrinsic value, competitors valuation, and company profile.
DCF Valuation
0PQ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
0PQ stock valuation using valuation multiples.
Wall St Estimates
0PQ price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
0PQ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other ProQR Therapeutics NV listings:
NASDAQ • USD
PRQR
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0PQ's stock price target?
Price Target
9.233 EUR

According to Wall Street analysts, the average 1-year price target for 0PQ is 9.233 EUR with a low forecast of 3.082 EUR and a high forecast of 16.019 EUR.

What is the Revenue forecast for ProQR Therapeutics NV?
Projected CAGR
50%

Over the last 12 years, the compound annual growth rate for Revenue has been 51%. The projected CAGR for the next 8 years is 50%.

Back to Top
ALPHA SPREAD
Follow us
Join 356,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett